Medline Inc. Class A Common Stock vs Invesco S&P 500 Momentum ETF — how do they compare? Medline Inc. Class A Common Stock trades at $35.75 (market cap $31.10B), while Invesco S&P 500 Momentum ETF trades at $152.51 (market cap $23.47B). The key difference: Medline Inc. Class A Common Stock is the larger of the two by market cap, and Invesco S&P 500 Momentum ETF is trading nearer its 52-week high, Medline Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Medline Inc. Class A Common Stock for 0 Days and Invesco S&P 500 Momentum ETF for 54 Days on average.
| MDLN | SPMO | |
|---|---|---|
Market Cap | $31.10B | $23.47B |
Volume | 4,471,639 | 2,035,258 |
Sector | Health | Broad Market / Factor |
52-Week High | $49.99 | $161.66 |
52-Week Low | $31.64 | $107.84 |
Typical Hold Time | 0 Days | 54 Days |
Enterprise Value | $41.07B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SPMO trades at $153.00 with minimal daily movement (+0.01%). The ETF maintains a bullish technical stance with strong moving average signals, though oscillators show neutral momentum. Recent portfolio rebalancing added 54 stocks including Apple and Merck, while removing Nvidia. Institutional interest grew with Envestnet Asset Management increasing its stake by 9.5% in Q2 2026.
SPMO offers concentrated exposure to S&P 500 momentum leaders with historical outperformance. Key risks include sector concentration in technology and semiconductors, plus higher volatility than the broader market. The fund's momentum strategy faces challenges during market rotations but maintains structural advantages for long-term growth investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Medline provides medical-surgical products and supply-chain solutions for healthcare providers. Its portfolio and distribution network serve hospitals, clinics, long-term care facilities, and other care settings.
Read more on MDLN →SPMO is designed to track the investment results of the S&P 500 Momentum Index. This index measures the performance of stocks in the S&P 500 that exhibit the highest momentum, or the greatest price appreciation, over the trailing 12 months, while excluding the most recent month. By investing in these high-momentum stocks, SPMO seeks to capitalize on the historical trend that stocks with strong recent performance tend to continue that performance in the near term, offering a systematic approach to factor investing within the large-cap U.S. equity market.
Read more on SPMO →